HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pedro Castelo-Branco Selected Research

Monoclonal Antibodies

1/2016A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pedro Castelo-Branco Research Topics

Disease

25Neoplasms (Cancer)
11/2022 - 06/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 01/2016
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
3Stomach Neoplasms (Stomach Cancer)
09/2021 - 01/2016
3Prostatic Neoplasms (Prostate Cancer)
02/2017 - 01/2016
2Breast Neoplasms (Breast Cancer)
12/2022 - 03/2019
2Carcinogenesis
12/2022 - 03/2018
2Fibrosis (Cirrhosis)
01/2022 - 01/2018
2Sepsis (Septicemia)
01/2020 - 01/2020
2Tics (Tic)
12/2014 - 01/2011
2Brain Neoplasms (Brain Tumor)
05/2014 - 02/2012
1Infertility (Sterility)
01/2022
1Neoplasm Metastasis (Metastasis)
09/2021
1Communicable Diseases (Infectious Diseases)
06/2021
1Infections
01/2020
1Critical Illness (Critically Ill)
01/2020
1Microsatellite Instability
05/2018
1Turcot syndrome
05/2018
1Lung Neoplasms (Lung Cancer)
03/2018
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2018
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2018
1Necrosis
01/2018
1Teratoma (Teratoid Tumor)
01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2017
1Urologic Neoplasms (Urological Cancer)
02/2017
1Chromothripsis
06/2016
1Genomic Instability
06/2016
1Medulloblastoma
12/2014
1Ependymoma
12/2014
1Diffuse Intrinsic Pontine Glioma
05/2014
1Disease Progression
05/2013
1Glioblastoma (Glioblastoma Multiforme)
01/2012
1Intellectual Disability (Idiocy)
01/2012
1Glioma (Gliomas)
01/2011

Drug/Important Bio-Agent (IBA)

19Biomarkers (Surrogate Marker)IBA
12/2022 - 05/2013
7Telomerase (Telomerase Reverse Transcriptase)IBA
11/2021 - 01/2011
6MicroRNAs (MicroRNA)IBA
01/2022 - 02/2017
6DNA (Deoxyribonucleic Acid)IBA
11/2021 - 02/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 06/2008
2Histone Deacetylase InhibitorsIBA
02/2017 - 06/2008
2imetelstatIBA
12/2014 - 01/2011
2Histones (Histone)IBA
05/2014 - 01/2012
1CollagenIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
12/2021
1cemiplimabIBA
12/2021
1Angiopoietin-2IBA
01/2020
1EnzymesIBA
01/2020
1Complement C3 (C3 Complement)IBA
01/2020
1Peroxidase (Myeloperoxidase)IBA
01/2020
1LactoperoxidaseIBA
01/2020
1Estrogen ReceptorsIBA
03/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
1CytokinesIBA
01/2019
1ChemokinesIBA
01/2019
1Complement System Proteins (Complement)IBA
03/2018
1CarcinogensIBA
03/2018
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Histone DemethylasesIBA
02/2017
1Antisense OligonucleotidesIBA
02/2017
1MethyltransferasesIBA
02/2017
1Monoclonal AntibodiesIBA
01/2016
1NivolumabIBA
01/2016
1Programmed Cell Death 1 ReceptorIBA
01/2016
1LithiumIBA
12/2014
1Radiation-Sensitizing AgentsIBA
12/2014
1RibonucleoproteinsIBA
12/2014
1dipinacoline glutamateIBA
05/2014
1RNA (Ribonucleic Acid)IBA
02/2012
1ChromatinIBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2012
1HeterochromatinIBA
01/2012
1theasinensin AIBA
06/2008
1Cyclin D1IBA
06/2008
1trichostatin A (A 300)IBA
06/2008

Therapy/Procedure

15Therapeutics
11/2022 - 06/2008
3Drug Therapy (Chemotherapy)
12/2021 - 12/2014
2Immunotherapy
12/2021 - 05/2018
1Lymph Node Excision (Lymph Node Dissection)
01/2018
1Precision Medicine
02/2017
1Transcutaneous Electric Nerve Stimulation (TENS)
06/2016
1Withholding Treatment
01/2011